Company / SG&A Expense
MARIMED INC. SG&A Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$26.1M
FY2025
5-year range
$20.7M / $27.6M
FY2021-FY2025
Trend
+2.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A Expense has increased for 3 consecutive years, from $21M in FY2022 to $26M in FY2025.
Based on SEC 10-K filings.
$26M in FY2025 with a 5-year CAGR of +21.4%.
Increased from $22M to $26M over the past 2 years.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +8.0%
- 5-Year CAGR
- +21.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- MARIMED INC.'s sg&a expense has grown for 3 consecutive years.
- 5-year CAGR of +21.4%, indicating consistent growth.
- In FY2025, sg&a expense increased 2.0% year-over-year.
- Peak sg&a expense was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $26.1M | +2.0% |
| FY2024 | $25.6M | +15.8% |
| FY2023 | $22.1M | +6.7% |
| FY2022 | $20.7M | -24.8% |
| FY2021 | $27.6M | +178.4% |
| FY2020 | $9.9M | +12.3% |
| FY2019 | $8.8M | -12.3% |
| FY2018 | $10.1M | +249.0% |
| FY2017 | $2.9M | +273.8% |
| FY2016 | $770.5K | +35.7% |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026